| Return Create A Forum - Home | |
| --------------------------------------------------------- | |
| MS Speaks | |
| https://msspeaks.createaforum.com | |
| --------------------------------------------------------- | |
| ***************************************************** | |
| MS Speaks | |
| ***************************************************** | |
| (Abst.) Safety and tolerability of conversion fo siponimod fro... | |
| 0 replies | |
| Discovery may help reduce MS drug side effects | |
| 0 replies | |
| More skin cancer reported to FDA from patients on certain oral... | |
| 0 replies | |
| (Abst.) Siponimod for MS | |
| 0 replies | |
| (Abst.) Are disease-modifying drugs for progressive MS worthwh... | |
| 0 replies | |
| Turning thumbs down on Mayzent for NHS England | |
| 0 replies | |
| Siponimod and liver injury research information (PubMed) | |
| 0 replies | |
| Woman w/SPMS in Australia unable to get siponimod, turns to Go... | |
| 0 replies | |
| Mayzent (siponimod, BAF312) for active SPMS, RRMS | |
| 14 replies | |
| ***************************************************** |